Christian (Chris) Barkey is a founder and the CEO of the Swissfinity Group, a European investment company in the advanced biotech sector. He has a background in product and business development in the medtech and biotechnology industries. Chris is former CEO of Barkey GmbH, now part of Azenta Life Sciences, AZTA (NASDAQ), a German medical device manufacturing company. Under the managerial leadership of Chris, the management board developed its business in over 70 countries, specializing in temperature management in hospital and intensive care settings, as well as in advanced biotechnology applications for the manufacturing and administration of cell and gene therapies. Chris was instrumental in the global implementation and success of the Barkey plasmatherm in the advanced therapies field, as well as in leading the M&A process of the company. Chris is a member of International Society for Cellular Therapy (ISCT) and the Alliance for Regenerative Medicine (ARM), as well as being a leader in his community and expert on medical device innovation and CGT process technology.